Cargando…
Rimonabant for treating tobacco dependence
Tobacco use continues to cause 5 million preventable deaths worldwide each year. Despite effective treatments being available, these are underutilized and cessation rates remain low. As tobacco use has complex physiological effects, there are multiple opportunities for novel pharmacological agents t...
Autores principales: | Steinberg, Michael B, Foulds, Jonathan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293960/ https://www.ncbi.nlm.nih.gov/pubmed/17703638 |
Ejemplares similares
-
Rimonabant: From RIO to Ban
por: Sam, Amir H., et al.
Publicado: (2011) -
Rimonabant, Gastrointestinal Motility and Obesity
por: Sun, Yan, et al.
Publicado: (2012) -
Rimonabant-induced depression in schizophrenia
por: Arasappa, Rashmi, et al.
Publicado: (2014) -
The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant
por: Murro, Ada Letícia B
Publicado: (2009) -
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
por: Waterlow, Mark, et al.
Publicado: (2007)